PRMT5-mediated RNF4 methylation promotes therapeutic resistance of APL cells to As
In: Cellular and molecular life sciences : CMLS, Jg. 79 (2022-01-25), Heft 6
Online
unknown
Zugriff:
Acute promyelocytic leukemia (APL) is a hematological malignancy driven by the oncoprotein PML-RARα, which can be treated with arsenic trioxide (As
Titel: |
PRMT5-mediated RNF4 methylation promotes therapeutic resistance of APL cells to As
|
---|---|
Autor/in / Beteiligte Person: | Xinping, Huang ; Yongfeng, Yang ; Dan, Zhu ; Yan, Zhao ; Min, Wei ; Ke, Li ; Hong-Hu, Zhu ; Xiaofeng, Zheng |
Link: | |
Zeitschrift: | Cellular and molecular life sciences : CMLS, Jg. 79 (2022-01-25), Heft 6 |
Veröffentlichung: | 2022 |
Medientyp: | unknown |
ISSN: | 1420-9071 (print) |
Schlagwort: |
|
Sonstiges: |
|